drugset / Trial / NCT02600130
Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase I, prospective, randomized, placebo-controlled, double-blinded study designed to test the safety and efficacy of LMSCs (Longeveron Mesenchymal Stem Cells) for the treatment of subjects with clinically diagnosed Alzheimer's disease.
Timeline
- Start
- 2016-10-10
- Primary completion
- 2020-09
- Completion
- 2021-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesenchymal stem cell | Cell therapy | 2e+07 cells | Intravenous |
| Subject | Mesenchymal stem cell | Cell therapy | 1e+08 cells | Intravenous |